VEGFA and neoplasm: Thus, blocking VEGF signaling enhances effector T-cell function by increasing their activation and delivery to the tumor (via tumor vessel normalization) on one hand and by inhibiting the VEGF-induced upregulation of inhibitory immune checkpoints, on the other hand [30,55].